The Epidemic | 10.2015

HIV Cancer Risk

TheEpidemic1015_MichaelJSilverbergMost notably: anal, colorectal and liver cancers.

Antiretroviral therapy has extended the lives of people with HIV, but living longer may increase these patients’ risk for certain cancers, reports HealthDay News.

A study of nearly 90,000 HIV patients revealed a rise in three types of cancer as the AIDS-causing virus has evolved from a probable death sentence into a manageable chronic condition.

“We found that the risk of some cancers, such as anal, colorectal and liver cancers, are increasing over time mainly because HIV patients are living longer,” said study lead author Dr. Michael Silverberg, of the Kaiser Permanente division of research in Oakland, Calif.

According to the U.S. National Cancer Institute, HIV patients have always faced a significantly higher cancer risk, most notably for Kaposi sarcoma, non-Hodgkin lymphoma and cervical cancer. That’s because of a generally weakened immune system and a higher rate of infection with cancer-related viruses.

HIV antiretroviral therapy, launched in 1996, has curbed some of that elevated risk. Now, the study team explained, HIV patients receiving antiretroviral therapy can look forward to a life span of roughly 75 years.

However, cancer risk has not been brought down to general population levels. And some cancer risk has actually risen since the advent of antiretroviral therapy, the researchers said.

Results of the study are published in the Annals of Internal Medicine.

As HIV has become a long-term chronic condition, “all sorts of health issues that patients and their doctors didn’t think they had to worry about are now something they have to worry about,” said study co-author Dr. Michael Horberg.

“It’s no longer enough just to survive,” he added. “You want to survive well.”

Share on FacebookTweet about this on TwitterShare on TumblrShare on LinkedInShare on Google+Email this to someone